HOOK Valuation

HOOKIPA Pharma Inc

Add to Watchlist

Advanced Chart

0.920

+0.01(1.099%)1D

Overview
Forecast
Valuation
Earnings

HOOK Relative Valuation

HOOK's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, HOOK is overvalued; if below, it's undervalued.

Historical Valuation

HOOKIPA Pharma Inc (HOOK) is now in the Fair zone, suggesting that its current forward PS ratio of 1.31 is considered Fairly compared with the five-year average of -1.96. The fair price of HOOKIPA Pharma Inc (HOOK) is between 0.43 to 3.04 according to relative valuation methord.

Relative Value

Fair Zone

0.43-3.04

Current Price：0.94

Fair

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

0.34

P/B

Median3y

0.70

Median5y

1.99

-428.33

FCF Yield

Median3y

-137.51

Median5y

-91.24

Competitors Valuation Multiple

The average P/S ratio for HOOK's competitors is 0.22, providing a benchmark for relative valuation. HOOKIPA Pharma Inc Corp (HOOK) exhibits a P/S ratio of 1.32, which is 500.00% above the industry average. Given its robust revenue growth of -94.52%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap